To gain a deeper understanding of whether the regions of tau containing the E2814 epitopes alter in disease, a mass spectrometry technique was employed to compare relative levels of tau tryptic peptides spanning the whole tau protein in the insoluble fractions from different tauopathy and control brains. The gene discussed is MAPT; the disease is tauopathy.